πŸ‡ΊπŸ‡Έ FDA
Patent

US 8062640

High affinity human antibodies to PCSK9

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 8062640 (High affinity human antibodies to PCSK9) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K39/08, A61P